Skip to main content
. 2024 Jun 6;9(4):952–958. doi: 10.1177/23969873241256813

Table 1.

Patient characteristics (n = 120).

Characteristics
Age, year mean (SD) 67.4 ± 15.9
Men, n (%) 66 (55.0)
Medical history
 Hypertension, n (%) 72/120 (60.0)
 Diabetes, n (%) 23/120 (19.2)
 Dyslipidemia, n (%) 30/120 (25.0)
 Current smoking, n (%) 32/120 (26.7)
 Previous stroke or TIA, n (%) 23/120 (19.2)
 Pre-stroke mRS > 1 39/120 (32.5)
 Antithrombotic treatment 61/119 (51.3)
Current AIS event
 Baseline NIHSS score, median (IQR) 1 17 (9–20)
 Baseline ASPECTS, median (IQR) 2 7 (5–9)
 IVT 58/120 (48.3)
First-line EVT strategy
 Stent retriever alone 8/118 (6.8)
 Contact aspiration alone 57/118 (48.3)
 Stent retriever and contact aspiration 53/118 (44.9)
YKL-40 plasma levels
 Before EVT, mean (SD), ng/ml 3 177 (111)
 Within 1 h after EVT, mean (SD), ng/ml 3 161 (112)
 24 h after EVT, mean (SD) ng/ml 3 298 (142)
Functional outcomes at 3 months
 Favorable outcome, n (%) 51/110 (46.4)
 Excellent outcome, n (%) 30/110 (27.3)

Values expressed as no/total no. (%) unless otherwise indicated. ASPECTS: Alberta stroke program early computed tomography score; TIA: transient ischemic attack; IQR: interquartile range; IVT: intravenous thrombolysis; NIHSS: national institutes of health stroke scale; SD: standard deviation.

1

2 missing data.

2

9 missing data.

3

1 missing data.